We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$256M
AUM Growth
-$6.25M
(-2.4%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-6.78%
Top 10 Holdings %
Top 10 Hldgs %
27.99%
Holding
234
New
14
Increased
21
Reduced
87
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$9.46M |
| 2 |
Amazon
AMZN
|
+$2.46M |
| 3 |
ResMed
RMD
|
+$1.94M |
| 4 |
Sony
SONY
|
+$1.42M |
| 5 |
Accenture
ACN
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$3.29M |
| 2 |
Biogen
BIIB
|
+$2.24M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.6M |
| 4 |
Eagle Materials
EXP
|
+$1.52M |
| 5 |
Bank of America
BAC
|
+$1.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Healthcare | 20.01% |
| 3 | Financials | 13.97% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Energy | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.9M | 4.65% |
312,514
+213,575
| +216% | +$9.46M |
|
2
Apple
AAPL
$4.9T
| $8.94M | 3.5% |
158,424
-15,560
| -9% | -$810K |
|
3
Microsoft
MSFT
$2.93T
| $8.1M | 3.17% |
70,795
-6,980
| -9% | -$757K |
|
|
MYOK
4
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $7.91M | 3.09% |
121,304
-56,000
| -32% | -$3.29M |
|
5
iShares Russell 2000 ETF
IWM
$82.2B
| $7.32M | 2.86% |
43,434
-1,953
| -4% | -$330K |
|
6
JPMorgan Chase
JPM
$907B
| $6.92M | 2.71% |
61,282
-5,530
| -8% | -$628K |
|
|
7
Amazon
AMZN
$2.66T
| $5.7M | 2.23% |
58,580
+26,200
| +81% | +$2.46M |
|
8
Weyerhaeuser
WY
$17.7B
| $5.06M | 1.98% |
3,200
-8,000
| -71% | -$278K |
|
9
Cisco
CSCO
$441B
| $4.97M | 1.94% |
102,131
-7,650
| -7% | -$344K |
|
10
Pfizer
PFE
$143B
| $4.74M | 1.85% |
113,320
-8,990
| -7% | -$346K |
|
11
Visa
V
$682B
| $4.63M | 1.81% |
30,865
+7,135
| +30% | +$1.01M |
|
|
12
Bank of America
BAC
$430B
| $4.43M | 1.73% |
150,476
-47,800
| -24% | -$1.46M |
|
|
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.09M | 1.6% |
153,729
| – | – |
|
14
Adobe
ADBE
$94.3B
| $4.05M | 1.58% |
14,988
+3,291
| +28% | +$849K |
|
15
Walmart Inc
WMT
$909B
| $3.91M | 1.53% |
124,863
-12,060
| -9% | -$369K |
|
16
Warner Bros
WBD
$67.4B
| $3.87M | 1.51% |
120,930
-4,230
| -3% | -$119K |
|
|
FISV
17
Fiserv Inc
FISV
$27B
| $3.78M | 1.48% |
45,878
-4,686
| -9% | -$368K |
|
|
OPLN
18
Openlane
OPLN
$4.18B
| $3.66M | 1.43% |
162,163
-13,950
| -8% | -$322K |
|
19
VeriSign
VRSN
$25.3B
| $3.55M | 1.39% |
22,177
+1,080
| +5% | +$165K |
|
20
Zions Bancorporation
ZION
$10.6B
| $3.4M | 1.33% |
67,705
-7,935
| -10% | -$419K |
|
|
WLL
21
DELISTED
Whiting Petroleum Corporation
WLL
| $3.19M | 1.25% |
801
-69
| -8% | -$254K |
|
|
FITB
22
Fifth Third Bancorp
FITB
$52.6B
| $3.14M | 1.23% |
112,450
-23,500
| -17% | -$690K |
|
|
STMP
23
DELISTED
Stamps.com, Inc.
STMP
| $3.13M | 1.23% |
13,845
-1,190
| -8% | -$298K |
|
|
STI
24
DELISTED
SunTrust Banks, Inc.
STI
| $3.1M | 1.21% |
46,417
-6,900
| -13% | -$492K |
|
25
Amgen
AMGN
$198B
| $3.05M | 1.19% |
14,733
+630
| +4% | +$124K |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Grace Capital held 234 positions worth $256M, down 2.4% from $262M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Grace Capital withdrew a net $17.3M in Q3 2018, closing 27 positions and reducing 87 holdings. Its most notable exit was Red Hat Inc, an estimated $1.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Grace Capital opened a new position in ResMed worth $2.04M.
- Grace Capital's largest Q3 2018 buy was ResMed: 17,720 shares worth $2.04M.
- Grace Capital added most to Global Blood Therapeutics, Inc. in Q3 2018, an estimated $9.46M increase.
- Grace Capital's biggest Q3 2018 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $3.29M.
- Grace Capital fully exited Red Hat Inc in Q3 2018, selling an estimated $1.6M.
- Grace Capital's ten largest holdings make up 28% of its $256M portfolio in Q3 2018.
- Grace Capital opened 14 new positions and closed 27 in Q3 2018.
- Grace Capital's portfolio value fell 2.4% quarter-over-quarter to $256M.
Based on Grace Capital's 13F filing for Q3 2018, filed 14 Nov 2018.